Clinical Trials Directory

Trials / Completed

CompletedNCT06167720

Suicide Risk Prediction in Cancer Patients

Suicide Risk Prediction in Cancer Patients: a Retrospective Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
176,000 (actual)
Sponsor
Fang Tang · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Previous studies have found that the suicide risk of cancer patients is influenced by socioeconomic factors, clinical characteristics, and environmental factors. But prediction model with multiple predictors for suicide risk in cancer patients is limited. The aim of this study is to assess the association of socioeconomic factors, clinical characteristics and meteorological factors with cancer patients' suicide, based on retrospective cohorts, and to establish a suicide risk prediction model with multiple predictors for cancer patients.

Detailed description

Cancer is a serious public health concern, with almost 10 million people dying from cancer in 2020. Previous studies have reported that cancer patients are more likely to die by suicide than the general public, especially in the six months to one year following cancer diagnosis. Since suicide is a result of the interaction of various factors such as socioeconomic factors, clinical characteristics, and environmental factors, it is necessary to construct a multivariate prediction model to predict the suicide risk in cancer patients. A retrospective cohort of cancer patients based on the Surveillance, Epidemiology, and End Results (SEER) program database was used to assess the association of socioeconomic factors, clinical characteristics and meteorological factors with cancer patients' suicide, and to establish prediction model with multiple predictors for cancer patients. Another retrospective cohort conducted from Shandong Multi-Center Healthcare Big Data Platform (SMCHBDP) was used to verify the predictive ability and generalization ability of the prediction model.

Conditions

Timeline

Start date
1979-01-01
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2023-12-12
Last updated
2023-12-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06167720. Inclusion in this directory is not an endorsement.